Business
Moderna, US in Covid-19 vaccine deal for up to $1.5 billion – Hindustan Times
It’s the latest in a string of supply deals reached to stockpile the most advanced vaccines in testing. Moderna shares gained 8.5% to $74.80 in late trading in New York.
Moderna Inc. reached a deal with the US to manufacture and distribute 100 million doses of its experimental vaccine for Covid-19, in a pact valued up to $1.5 billion, the company said Tuesday.
“I’m pleased to announce we’ve reached an agreement with Moderna to manufacture and deliver 100m doses of the coronavirus vaccine candidate,” President Donald Trump said at a White House briefing. “We’re on track to rapidly produce 100 million doses as soon as the vaccine is approved.”
It’s the latest in…
-
General17 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
General22 hours agoEnergy chiefs say net zero ‘irreversible’ even though bills unlikely to fall ‘for a decade’
-
Business12 hours agoWhat it means for shareholders
-
General11 hours agoKim Kardashian not deterred by bar failure